Novo Holdings leads 225m USD investment in Maplight Therapeutics
US biotech company Maplight Therapeutics has raised 225m USD in a Series C financing round led by Novo Holdings together with a number of new and existing investors.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.